Progress in the development of pandemic influenza vaccines and their production technologies
Identifieur interne : 002735 ( Main/Exploration ); précédent : 002734; suivant : 002736Progress in the development of pandemic influenza vaccines and their production technologies
Auteurs : O. I. Kiselev [Russie]Source :
- Applied Biochemistry and Microbiology [ 0003-6838 ] ; 2010-12-01.
English descriptors
- KwdEn :
Abstract
Abstract: This article analyzes the current situation in the field of construction and production of pandemic influenza vaccines. The main task of protecting the population against influenza pandemics requires state-of-the-art approaches to the construction of influenza vaccines to be based on reassortment and genetic engineering techniques, including the analysis of primary structures of influenza viral genes, synthesis and cloning of the main viral genes, reverse genetics techniques, and banks of plasmids bearing basic viral genes. Reassortant technologies are now giving way to new approaches for objective reasons. The state-of-the-art technologies provide safety not only at the laboratories where vaccine viruses are constructed but also make the production process wholly safe. We are using the following approaches to the development of industrial production: use of nanoparticles and nanoemulsions as functional adjuvants, construction of totally-safe strains for live attenuated influenza vaccines with deletions of molecular determinants of pathogenicity, application of protein and chemical chaperones to provide self-assembly of haemagglutinin molecules of the H1N1v-2009 virus, and impregnation of whole-virion preparations with nanoparticles to enhance antigenicity.
Url:
DOI: 10.1134/S0003683810090024
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001764
- to stream Istex, to step Curation: 001764
- to stream Istex, to step Checkpoint: 000988
- to stream Main, to step Merge: 002774
- to stream Main, to step Curation: 002735
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Progress in the development of pandemic influenza vaccines and their production technologies</title><author><name sortKey="Kiselev, O I" sort="Kiselev, O I" uniqKey="Kiselev O" first="O. I." last="Kiselev">O. I. Kiselev</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5E250AA662677CE6524DFC014929891F602B2A03</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1134/S0003683810090024</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-X1PJB7GZ-W/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001764</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001764</idno><idno type="wicri:Area/Istex/Curation">001764</idno><idno type="wicri:Area/Istex/Checkpoint">000988</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000988</idno><idno type="wicri:doubleKey">0003-6838:2010:Kiselev O:progress:in:the</idno><idno type="wicri:Area/Main/Merge">002774</idno><idno type="wicri:Area/Main/Curation">002735</idno><idno type="wicri:Area/Main/Exploration">002735</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Progress in the development of pandemic influenza vaccines and their production technologies</title><author><name sortKey="Kiselev, O I" sort="Kiselev, O I" uniqKey="Kiselev O" first="O. I." last="Kiselev">O. I. Kiselev</name><affiliation wicri:level="1"><country xml:lang="fr">Russie</country><wicri:regionArea>Research Institute of Influenza, North Western Division, Russian Academy of Medical Sciences (RAMS), 197376, St. Petersburg</wicri:regionArea><wicri:noRegion>St. Petersburg</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Russie</country></affiliation></author></analytic><monogr></monogr><series><title level="j">Applied Biochemistry and Microbiology</title><title level="j" type="abbrev">Appl Biochem Microbiol</title><idno type="ISSN">0003-6838</idno><idno type="eISSN">1608-3024</idno><imprint><publisher>SP MAIK Nauka/Interperiodica</publisher><pubPlace>Dordrecht</pubPlace><date type="published" when="2010-12-01">2010-12-01</date><biblScope unit="volume">46</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="815">815</biblScope><biblScope unit="page" to="830">830</biblScope></imprint><idno type="ISSN">0003-6838</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0003-6838</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>adjuvants</term><term>antigens</term><term>live attenuated vaccines</term><term>replication-deficient vaccines</term><term>vaccines</term><term>viral proteins</term><term>virus-like particles</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: This article analyzes the current situation in the field of construction and production of pandemic influenza vaccines. The main task of protecting the population against influenza pandemics requires state-of-the-art approaches to the construction of influenza vaccines to be based on reassortment and genetic engineering techniques, including the analysis of primary structures of influenza viral genes, synthesis and cloning of the main viral genes, reverse genetics techniques, and banks of plasmids bearing basic viral genes. Reassortant technologies are now giving way to new approaches for objective reasons. The state-of-the-art technologies provide safety not only at the laboratories where vaccine viruses are constructed but also make the production process wholly safe. We are using the following approaches to the development of industrial production: use of nanoparticles and nanoemulsions as functional adjuvants, construction of totally-safe strains for live attenuated influenza vaccines with deletions of molecular determinants of pathogenicity, application of protein and chemical chaperones to provide self-assembly of haemagglutinin molecules of the H1N1v-2009 virus, and impregnation of whole-virion preparations with nanoparticles to enhance antigenicity.</div></front></TEI><affiliations><list><country><li>Russie</li></country></list><tree><country name="Russie"><noRegion><name sortKey="Kiselev, O I" sort="Kiselev, O I" uniqKey="Kiselev O" first="O. I." last="Kiselev">O. I. Kiselev</name></noRegion><name sortKey="Kiselev, O I" sort="Kiselev, O I" uniqKey="Kiselev O" first="O. I." last="Kiselev">O. I. Kiselev</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002735 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002735 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:5E250AA662677CE6524DFC014929891F602B2A03
|texte= Progress in the development of pandemic influenza vaccines and their production technologies
}}
| This area was generated with Dilib version V0.6.33. |  |